Hemostasis in Patients With Idiopathic Thrombocytopenic Purpura
1 other identifier
observational
20
1 country
1
Brief Summary
The investigators are trying to investigate the coagulation status of idiopathic (immune) thrombocytopenic purpura patients by measuring the platelet count, coagulation battery, von Willebrand factor level, thromboelastography.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Apr 2012
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2012
CompletedFirst Submitted
Initial submission to the registry
April 2, 2012
CompletedFirst Posted
Study publicly available on registry
April 5, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedDecember 25, 2013
December 1, 2013
8 months
April 2, 2012
December 24, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
maximum clot formation
thromboelastography parameters performed within 3 hours of blood sampling
within 3 hour of blood sampling
Secondary Outcomes (9)
platelet count
within 1 hours of blood sampling
Coagulation battery results
within 1 hour after blood sampling
von Willebrand factor antigen
within 3 hours of blood sample
clotting time
within 3 hours of blood sampling
alpha angle
within 3 hours of blood sample
- +4 more secondary outcomes
Study Arms (2)
chronic ITP group
ITP patients with elevated level of vWF, ITP patients with preserved MA of thromboelastography
acute ITP group
ITP patients with normal level of vWF, ITP patients with decreased MA of thromboelastography
Eligibility Criteria
Those who visits the outpatients clinic of Samsung Medical Center with a diagnosis of idiopathic (immune) thrombocytopenic purpura between March, 2012 and February, 2013.
You may qualify if:
- Those who visits the outpatients clinic of Samsung Medical Center with a diagnosis of idiopathic (immune) thrombocytopenic purpura (ITP)between March, 2012 and February, 2013.
- Those with age between 20 and 70 yrs old
You may not qualify if:
- Those with other causes of thrombocytopenia other than ITP
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Samsung Medical Center
Seoul, 135-710, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gaab Soo Kim, MD, PhD
Samsung Medical Center
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
April 2, 2012
First Posted
April 5, 2012
Study Start
April 1, 2012
Primary Completion
December 1, 2012
Study Completion
December 1, 2012
Last Updated
December 25, 2013
Record last verified: 2013-12